• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用声诺维进行洗脱参数成像以增强肝脏局灶性病变的鉴别诊断

Washout-parametric imaging with Sonazoid for enhanced differentiation of focal liver lesions.

作者信息

Kakegawa Tatsuya, Sugimoto Katsutoshi, Kamiyama Naohisa, Hashimoto Hiroshi, Takahashi Hiroshi, Wada Takuya, Yoshimasu Yu, Takeuchi Hirohito, Nakayama Ryohei, Sakamaki Kentaro, Itoi Takao

机构信息

Department of Gastroenterology and Hepatology, Tokyo Medical University, Tokyo, Japan.

Ultrasound General Imaging, GE HealthCare, Tokyo, Japan.

出版信息

Ultrasonography. 2024 Nov;43(6):457-468. doi: 10.14366/usg.24100. Epub 2024 Aug 5.

DOI:10.14366/usg.24100
PMID:39370861
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11532521/
Abstract

PURPOSE

The study aimed to compare the diagnostic performance of washout-parametric imaging (WOPI) with that of conventional contrast-enhanced ultrasound (cCEUS) in differentiating focal liver lesions (FLLs).

METHODS

A total of 181 FLLs were imaged with contrast-enhanced ultrasound using Sonazoid, and the recordings were captured for 10 minutes in a prospective setting. WOPI was constructed from three images, depicting the arterial phase (peak enhancement), the early portal venous phase (1-minute post-injection), and the vasculo-Kupffer phase (5 or 10 minutes post-injection). The intensity variations in these images were color-coded and superimposed to produce a single image representing the washout timing across the lesions. From the 181 FLLs, 30 hepatocellular carcinomas (HCCs), 30 non-HCC malignancies, and 30 benign lesions were randomly selected for an observer study. Both techniques (cCEUS and WOPI) were evaluated by four off-site readers. They classified each lesion as benign or malignant using a continuous rating scale, with the endpoints representing "definitely benign" and "definitely malignant." The diagnostic performance of cCEUS and WOPI was compared using the area under the receiver operating characteristic curve (AUC) with the DeLong test. Interobserver agreement was assessed using the intraclass correlation coefficient (ICC).

RESULTS

The difference in average AUC values between WOPI and cCEUS was 0.0062 (95% confidence interval, -0.0161 to 0.0285), indicating no significant difference between techniques. The interobserver agreement was higher for WOPI (ICC, 0.77) than cCEUS (ICC, 0.67).

CONCLUSION

The diagnostic performance of WOPI is comparable to that of cCEUS in differentiating FLLs, with superior interobserver agreement.

摘要

目的

本研究旨在比较洗脱参数成像(WOPI)与传统对比增强超声(cCEUS)在鉴别肝脏局灶性病变(FLLs)方面的诊断性能。

方法

使用声诺维对181个FLLs进行对比增强超声成像,并在前瞻性研究中记录10分钟。WOPI由三张图像构建而成,分别描绘动脉期(峰值增强)、早期门静脉期(注射后1分钟)和血管-库普弗细胞期(注射后5或10分钟)。对这些图像中的强度变化进行颜色编码并叠加,以生成一张代表病变洗脱时间的单一图像。从181个FLLs中随机选取30个肝细胞癌(HCCs)、30个非HCC恶性肿瘤和30个良性病变进行观察者研究。由四位非现场阅片者对两种技术(cCEUS和WOPI)进行评估。他们使用连续评分量表将每个病变分类为良性或恶性,端点分别代表“肯定良性”和“肯定恶性”。使用接受者操作特征曲线下面积(AUC)和德龙检验比较cCEUS和WOPI的诊断性能。使用组内相关系数(ICC)评估观察者间的一致性。

结果

WOPI和cCEUS的平均AUC值差异为0.0062(95%置信区间,-0.0161至0.0285),表明两种技术之间无显著差异。WOPI的观察者间一致性(ICC,0.77)高于cCEUS(ICC,0.67)。

结论

在鉴别FLLs方面,WOPI的诊断性能与cCEUS相当,且观察者间一致性更高。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7809/11532521/01acfc68ea9e/usg-24100f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7809/11532521/7aab1b1229b2/usg-24100f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7809/11532521/58460d9a94bc/usg-24100f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7809/11532521/49628534ee73/usg-24100f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7809/11532521/e4fb78510e50/usg-24100f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7809/11532521/316cdc58ce8a/usg-24100f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7809/11532521/01acfc68ea9e/usg-24100f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7809/11532521/7aab1b1229b2/usg-24100f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7809/11532521/58460d9a94bc/usg-24100f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7809/11532521/49628534ee73/usg-24100f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7809/11532521/e4fb78510e50/usg-24100f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7809/11532521/316cdc58ce8a/usg-24100f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7809/11532521/01acfc68ea9e/usg-24100f6.jpg

相似文献

1
Washout-parametric imaging with Sonazoid for enhanced differentiation of focal liver lesions.使用声诺维进行洗脱参数成像以增强肝脏局灶性病变的鉴别诊断
Ultrasonography. 2024 Nov;43(6):457-468. doi: 10.14366/usg.24100. Epub 2024 Aug 5.
2
A combined model based on radiomics features of Sonazoid contrast-enhanced ultrasound in the Kupffer phase for the diagnosis of well-differentiated hepatocellular carcinoma and atypical focal liver lesions: a prospective, multicenter study.基于声诺维对比增强超声门脉期放射组学特征的联合模型在诊断高分化肝细胞癌和不典型局灶性肝脏病变中的应用:一项前瞻性、多中心研究。
Abdom Radiol (NY). 2024 Oct;49(10):3427-3437. doi: 10.1007/s00261-024-04253-4. Epub 2024 May 14.
3
Differentiation of focal liver lesions: usefulness of parametric imaging with contrast-enhanced US.肝脏局灶性病变的鉴别诊断:超声造影参数成像的应用价值。
Radiology. 2011 Oct;261(1):300-10. doi: 10.1148/radiol.11101866. Epub 2011 Jul 11.
4
Impact of Hepatocellular Carcinoma Tumor Size on Sonazoid Contrast-Enhanced Ultrasound Enhancement Features.肝癌肿瘤大小对 SonoVue 超声造影增强特征的影响。
Ultrasound Med Biol. 2024 Jan;50(1):39-46. doi: 10.1016/j.ultrasmedbio.2023.08.022. Epub 2023 Sep 30.
5
R2* value derived from multi-echo Dixon technique can aid discrimination between benign and malignant focal liver lesions.多回波 Dixon 技术衍生的 R2* 值有助于鉴别肝脏局灶性良恶性病变。
World J Gastroenterol. 2021 Mar 28;27(12):1182-1193. doi: 10.3748/wjg.v27.i12.1182.
6
Contrast-enhanced ultrasound (CEUS) has excellent diagnostic accuracy in differentiating focal liver lesions: results from a Swiss tertiary gastroenterological centre.超声造影(CEUS)在鉴别局灶性肝脏病变方面具有出色的诊断准确性:来自瑞士一家三级胃肠病学中心的结果。
Swiss Med Wkly. 2019 Jun 30;149:w20087. doi: 10.4414/smw.2019.20087. eCollection 2019 Jun 17.
7
Contrast-Enhanced Ultrasound With Perfluorobutane for Hepatocellular Carcinoma Diagnosis: Comparison of Imaging Phases and Diagnostic Criteria.对比增强超声联合全氟丁烷在肝细胞癌诊断中的应用:成像相和诊断标准的比较。
AJR Am J Roentgenol. 2024 Feb;222(2):e2330156. doi: 10.2214/AJR.23.30156. Epub 2023 Nov 22.
8
Assessment of arterial-phase hyperenhancement and late-phase washout of hepatocellular carcinoma-a meta-analysis of contrast-enhanced ultrasound (CEUS) with SonoVue® and Sonazoid®.评估肝细胞癌的动脉期增强和晚期廓清: SonoVue® 和 Sonazoid® 超声造影的荟萃分析。
Eur Radiol. 2024 Jun;34(6):3795-3812. doi: 10.1007/s00330-023-10371-2. Epub 2023 Nov 22.
9
Value of Sonazoid-enhanced ultrasonography in characterizing indeterminate focal liver lesions on gadoxetic acid-enhanced liver MRI in patients without risk factors for hepatocellular carcinoma.钆塞酸增强磁共振成像中对无肝细胞癌危险因素患者局灶性肝脏病变性质不确定的超声造影表现评估。
PLoS One. 2024 May 24;19(5):e0304352. doi: 10.1371/journal.pone.0304352. eCollection 2024.
10
Multiphase convolutional dense network for the classification of focal liver lesions on dynamic contrast-enhanced computed tomography.基于动态对比增强 CT 的多相卷积密集网络的肝脏局灶性病变分类。
World J Gastroenterol. 2020 Jul 7;26(25):3660-3672. doi: 10.3748/wjg.v26.i25.3660.

本文引用的文献

1
Modified CEUS LI-RADS using Sonazoid for the diagnosis of hepatocellular carcinoma.使用声诺维的改良CEUS LI-RADS用于肝细胞癌的诊断。
Ultrasonography. 2023 Jul;42(3):388-399. doi: 10.14366/usg.23065. Epub 2023 May 31.
2
Diagnosing Hepatocellular Carcinoma Using Sonazoid Contrast-Enhanced Ultrasonography: 2023 Guidelines From the Korean Society of Radiology and the Korean Society of Abdominal Radiology.使用 SonoVue 对比增强超声诊断肝细胞癌:韩国放射学会和韩国腹部放射学会 2023 年指南。
Korean J Radiol. 2023 Jun;24(6):482-497. doi: 10.3348/kjr.2023.0324.
3
Perfluorobutane-enhanced ultrasonography with a Kupffer phase: improved diagnostic sensitivity for hepatocellular carcinoma.
含氟丁烷增强超声造影的 Kupffer 期成像:提高肝细胞癌的诊断灵敏度。
Eur Radiol. 2022 Dec;32(12):8507-8517. doi: 10.1007/s00330-022-08900-6. Epub 2022 Jun 16.
4
Contrast-Enhanced Ultrasound Using Perfluorobutane: Impact of Proposed Modified LI-RADS Criteria on Hepatocellular Carcinoma Detection.使用全氟丁烷的超声造影:拟议改良 LI-RADS 标准对肝细胞癌检测的影响。
AJR Am J Roentgenol. 2022 Sep;219(3):434-443. doi: 10.2214/AJR.22.27521. Epub 2022 Apr 20.
5
Noninvasive Diagnosis of Hepatocellular Carcinoma on Sonazoid-Enhanced US: Value of the Kupffer Phase.索拉非尼增强超声对肝细胞癌的无创诊断:库普弗细胞期的价值
Diagnostics (Basel). 2022 Jan 7;12(1):141. doi: 10.3390/diagnostics12010141.
6
Arrival-Time Parametric Imaging in Contrast-Enhanced Ultrasound for Diagnosing Fibrosis in Primary Biliary Cholangitis.对比增强超声到达时间参数成像在原发性胆汁性胆管炎纤维化诊断中的应用。
Ultrasound Q. 2022 Jun 1;38(2):191-199. doi: 10.1097/RUQ.0000000000000591.
7
CT/MRI and CEUS LI-RADS Major Features Association with Hepatocellular Carcinoma: Individual Patient Data Meta-Analysis.CT/MRI 和 CEUS LI-RADS 主要特征与肝细胞癌的关联:个体患者数据的荟萃分析。
Radiology. 2022 Feb;302(2):326-335. doi: 10.1148/radiol.2021211244. Epub 2021 Nov 16.
8
Verification of modified receiver-operating characteristic software using simulated rating data.使用模拟评级数据验证改良的接收者操作特征软件。
Radiol Phys Technol. 2018 Dec;11(4):406-414. doi: 10.1007/s12194-018-0479-9. Epub 2018 Sep 22.
9
Prospective Validation of Intra- and Interobserver Reproducibility of a New Point Shear Wave Elastographic Technique for Assessing Liver Stiffness in Patients with Chronic Liver Disease.一种用于评估慢性肝病患者肝脏硬度的新型点剪切波弹性成像技术的观察者内和观察者间可重复性的前瞻性验证
Korean J Radiol. 2017 Nov-Dec;18(6):926-935. doi: 10.3348/kjr.2017.18.6.926. Epub 2017 Sep 21.
10
Ultrasound diagnostic criteria for hepatic tumors.肝脏肿瘤的超声诊断标准。
J Med Ultrason (2001). 2014 Jan;41(1):113-23. doi: 10.1007/s10396-013-0500-1.